Ageing@Coimbra
Description: Luzitin, S.A. is a pharmaceutical company focused on the pursuit of innovative solutions for photodynamic therapy (PDT) and photodiagnosis (PDD). Luzitin is open to different investment modalities, from equity sharing to licensing and/or co-development of its therapeutic solutions. There are three unique opportunities for partnership development of Redaporfin: Redaporfin combined with immune checkpoint inhibitors based on its meaningful in-vivo preclinical immunologic effects to treat melanoma. | Redaporfin
health (20319) pdd (69) research&development (67) pdt (37) cancer treatments (22) photodynamic therapy (7) oncology treatment (5) luzitin (1) redaporfin (1) photodiagnosis (1)
Photodynamic therapy
Why you should select Luzitin?
Santos L, L, Oliveira J, Monteiro E, Santos J, Sarmento C Case Rep Oncol 2018;11:769-776
Ageing@Coimbra